دورية أكاديمية

Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study

التفاصيل البيبلوغرافية
العنوان: Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study
المؤلفون: Siddiqi, Tanya *, Maloney, David G, Kenderian, Saad S, Brander, Danielle M, Dorritie, Kathleen, Soumerai, Jacob, Riedell, Peter A, Shah, Nirav N, Nath, Rajneesh, Fakhri, Bita, Stephens, Deborah M, Ma, Shuo, Feldman, Tatyana, Solomon, Scott R, Schuster, Stephen J, Perna, Serena K, Tuazon, Sherilyn A, Ou, San-San, Papp, Eniko, Peiser, Leanne, Chen, Yizhe, Wierda, William G
المصدر: In The Lancet 19 August 2023 402(10402):641-654
قاعدة البيانات: ScienceDirect
الوصف
تدمد:01406736
DOI:10.1016/S0140-6736(23)01052-8